new glp-1 agonists Frontiers What are GLP-1s? | Mendinground
Description
8 Cost The high cost of these medications is a barrier to many patients continuing them, with US list prices or $12,000-16,000 per year, and over $6500 a year at maximum discount

Mayendraraj, A., Rosenkilde, M

Conclusions SGLT-2 inhibitors and GLP-1RA are superior to DPP-4 inhibitors in reducing the risk of most cardiorenal outcomes

Risks of GLP-1 weight loss medication GLP-1 (Glucagon-Like Peptide-1) receptor agonists, like Ozempic, bring tangible benefits in managing Type 2 diabetes and aiding weight loss but also come with potential risks

First, market competition may not reduce prices as dramatically as some expect

PMID: 27295427